Attached files

file filename
EX-10.11 - ADMA BIOLOGICS, INC.e609275_ex10-11.htm
8-K - ADMA BIOLOGICS, INC.e609275_8k-adma.htm
EX-3.1 - ADMA BIOLOGICS, INC.e609275_ex3-1.htm
EX-2.2 - ADMA BIOLOGICS, INC.e609275_ex2-2.htm
EX-4.2 - ADMA BIOLOGICS, INC.e609275_ex4-2.htm
EX-10.3 - ADMA BIOLOGICS, INC.e609275_ex10-3.htm
EX-10.6 - ADMA BIOLOGICS, INC.e609275_ex10-6.htm
EX-99.2 - ADMA BIOLOGICS, INC.e609275_ex99-2.htm
EX-10.2 - ADMA BIOLOGICS, INC.e609275_ex10-2.htm
EX-10.1 - ADMA BIOLOGICS, INC.e609275_ex10-1.htm
EX-99.1 - ADMA BIOLOGICS, INC.e609275_ex99-1.htm
EX-10.4 - ADMA BIOLOGICS, INC.e609275_ex10-4.htm
EX-10.7 - ADMA BIOLOGICS, INC.e609275_ex10-7.htm
EX-10.8 - ADMA BIOLOGICS, INC.e609275_ex10-8.htm
EX-10.9 - ADMA BIOLOGICS, INC.e609275_ex10-9.htm
EX-10.5 - ADMA BIOLOGICS, INC.e609275_ex10-5.htm
EX-10.10 - ADMA BIOLOGICS, INC.e609275_ex10-10.htm
EX-10.12 - ADMA BIOLOGICS, INC.e609275_ex10-12.htm
EX-2.1 - ADMA BIOLOGICS, INC.e609275_ex2-1.htm
 
805 Third Ave., New York, NY 10022
Voice: (212) 838-5100     Fax: (212) 838-2676
 
February 13, 2012
 
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
 
Ladies and Gentlemen:

We have read Item 4.01 of Form 8-K dated February 13, 2012 of R&R Acquisition VI, Inc. (renamed ADMA Biologics, Inc.) and are in agreement with the statements contained in the first sentence with regards to the dismissal of Sherb & Co., LLP and the second and third paragraphs therein in their entirety.  We have no basis to agree or disagree with other statements of the Registrant contained therein.

 
/s/ Sherb & Co., LLP
Certified Public Accountants